320 Participants Needed

Social Services Support for Heart Failure

Recruiting at 2 trial locations
TB
SF
Overseen ByStacy Farr, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Saint Luke's Health System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The objective of this program is to improve post-acute care coordination for necessary social services for patients leaving the hospital after recovering from an episode of decompensated heart failure.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Managed Services, IT Managed Services, Outsourced IT Services, IT Service Management, IT Operations Management, IT Service Delivery for heart failure?

Research shows that disease management programs, which include coordinated care and patient education, improve outcomes for heart failure patients by reducing hospital admissions and mortality. Additionally, nurse-led follow-up care has been found to lower the risk of death in heart failure patients.12345

How is the Managed Services treatment for heart failure different from other treatments?

The Managed Services treatment for heart failure is unique because it involves providing social services support, which focuses on managing care through specialized services rather than traditional medical interventions. This approach aims to reduce hospital readmissions and improve patient outcomes by coordinating care and support in the community.678910

Eligibility Criteria

This trial is for Missouri or Kansas residents aged 18-99 who are currently hospitalized due to acute heart failure. It's not open to those under 18 or over 99.

Inclusion Criteria

I am currently hospitalized for sudden heart failure.
I am between 18 and 99 years old.
Resident of Missouri or Kansas

Exclusion Criteria

I am between 18 and 99 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either standard medical care or managed services after discharge, including in-home assessment and care coordination

2 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 years

Treatment Details

Interventions

  • Managed Services
Trial OverviewThe study is testing a program designed to improve the coordination of social services after patients with heart failure leave the hospital, aiming to reduce rehospitalization rates.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Managed Services After DischargeExperimental Treatment1 Intervention
Subjects receive in-home assessment and care coordination/connection with community resources after hospital discharge
Group II: Standard Of Care - No Managed ServicesActive Control1 Intervention
Subjects receive standard medical care and follow-up after hospital discharge

Find a Clinic Near You

Who Is Running the Clinical Trial?

Saint Luke's Health System

Lead Sponsor

Trials
42
Recruited
12,600+

Truman Medical Center

Collaborator

Trials
10
Recruited
301,000+

University of Missouri, Kansas City

Collaborator

Trials
73
Recruited
34,600+

Mid America Regional Council

Collaborator

Trials
1
Recruited
320+

Findings from Research

Effective disease management programs for heart failure can significantly improve patient outcomes by focusing on coordinated care, patient education, and monitoring, which helps keep patients out of the hospital and reduces mortality.
The main challenges in implementing these programs are changing physician practices and ensuring patient compliance, highlighting the need to effectively utilize existing technologies rather than just developing new ones.
Heart failure and disease management.Leider, HL.[2019]
In a randomized controlled trial involving heart failure patients, a reciprocal peer support program did not show any significant improvement in rehospitalization rates or quality of life compared to standard nurse care management, despite the program's design to enhance patient engagement.
Only 55% of participants in the peer support program actively engaged in the intended peer communication, suggesting that low participation may have contributed to the lack of observed benefits.
Randomized controlled effectiveness trial of reciprocal peer support in heart failure.Heisler, M., Halasyamani, L., Cowen, ME., et al.[2022]
The implementation of an outpatient inotropic infusion unit and case management at a community hospital led to a significant reduction in hospital admissions and inpatient length of stay for patients with congestive heart failure.
Alongside decreased healthcare costs, patient satisfaction and functional status improved, demonstrating the effectiveness of the new care model.
Heart failure management.Warner, PM., Hutchinson, C.[2019]

References

Heart failure and disease management. [2019]
Randomized controlled effectiveness trial of reciprocal peer support in heart failure. [2022]
Heart failure management. [2019]
Evidence-based heart failure performance measures and clinical outcomes: a systematic review. [2018]
Nurse support is most effective follow-up for heart failure patients. [2019]
6.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Chronic heart failure: New challenges and new perspectives]. [2018]
Multidisciplinary interventions in heart failure. [2018]
Does case management for patients with heart failure based in the community reduce unplanned hospital admissions? A systematic review and meta-analysis. [2021]
The impact of an integrated heart failure service in a medium-sized district general hospital. [2020]
Evaluating the effect of setting up a nurse-led heart failure service. [2007]